Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | XOM | TTE |
|---|---|---|
| Price | $162.51 | $91.78 |
| Change today | ▲ 0.79% | ▲ 0.11% |
| Market cap | $668.23B | $202.73B |
| Return, 3 months | +19.5% | +19.6% |
| Return, year to date | +37.8% | +45.5% |
| Return, 1 year | +46.0% | +59.9% |
| P/E (TTM) | 20.9 | 11.5 |
| P/B | 2.6 | 1.6 |
| P/E percentile vs own 5y | 90th | 84th |
| Dividend yield | 2.51% | 4.29% |
| Revenue growth (YoY, latest qtr) | +44.1% | +27.8% |
| Net profit growth (YoY) | +102.4% | +99.4% |
| Gross margin | 20.6% | 30.7% |
| Operating margin | 10.7% | 13.7% |
| Net margin | 9.1% | 9.1% |
| Return on equity | 12.6% | 14.6% |
| Analyst target vs. price | +4.7% | +7.3% |
| Analyst buy share | 50% | 79% |
| RSI (14) | 51 | 54 |
| 30-day volatility | 25.7% | 19.5% |
| Max drawdown, 1 year | -20.1% | -18.0% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.